# SV Life Sciences: portfolio, investments and team

> SV Life Sciences is a vc firm. 121 investments on record, latest Mar 2017. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/sv-life-sciences (Millionrounds; every figure on the page links to its filing or article)

[Investor](https://millionrounds.com/investors)

# SV Life Sciences

Last cheque observed Mar 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet New fund $421M, Mar 2022 VC firm

Series B Series A Series C

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 121 on record

Since the last cheque **3507** days **00** hrs **00** min **00** sec

Median round **$30M** Rounds led **0 of 121** Sole investor **5 rounds** Exits **13 from the portfolio** Mostly in **United States, 69%**

Pitch SV Life Sciences

## SV Life Sciences highlights

- 01 121 rounds on record
- 02 Mostly Series B and Series A: 58% of its rounds
- 03 Sole investor in 5 rounds, median $12M
- 04 13 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **121 appearances**

- **2017** 1 round
- **Mar** **[Pulmocide](https://millionrounds.com/company/pulmocide)** Series B · GB · Techcitynews **$30M** Sole investor
- **2016** 2 rounds
- **Sept** **[Artios Pharma](https://millionrounds.com/company/artios-pharma)** Series A · GB · FinSMEs **$33M** With 1 other
- **Aug** **[Aligned TeleHealth](https://millionrounds.com/company/aligned-telehealth)** Series A · US · FinSMEs **$12M** With 1 other
- **2015** 5 rounds
- **Aug** **[ReShape Medical](https://millionrounds.com/company/reshape-medical)** Series D · US **$38M** With 5 others
- **Aug** **[Avitide](https://millionrounds.com/company/avitide)** Series C · US **$7.6M** With 4 others
- **Jul** **[KalVista Pharmaceuticals](https://millionrounds.com/company/kalvista-pharmaceuticals)** Series B · GB **$33M** With 4 others
- **Jul** **[Autifony Therapeutics](https://millionrounds.com/company/autifony-therapeutics)** Series A · GB **$12M** With 4 others
- **Jan** **[Schweiger Dermatology](https://millionrounds.com/company/schweiger-dermatology)** Series A · US **$12M** Sole investor
- **2014** 10 rounds
- **Dec** **[CardioKinetix](https://millionrounds.com/company/cardiokinetix)** Series F · US **$50M** With 4 others
- **Oct** **[Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics)** Series A · GB **$32M** With 4 others
- **Sept** **[AcuFocus](https://millionrounds.com/company/acufocus)** Venture · US **$21M** With 5 others
- **Jul** **[EBR Systems](https://millionrounds.com/company/ebr-systems)** Venture · US **$20M** With 5 others
- **Jun** **[Spinal Kinetics](https://millionrounds.com/company/spinal-kinetics)** Venture · US **$34M** With 4 others
- **May** **[CardioFocus](https://millionrounds.com/company/cardiofocus)** Debt · US **$2.4M** With 7 others
- **Apr** **[PanOptica](https://millionrounds.com/company/panoptica)** Series B · US **$45M** With 2 others
- **Feb** **[Thesan Pharmaceuticals](https://millionrounds.com/company/thesan-pharmaceuticals)** Series B **$49M** With 6 others
- **Jan** **[AqueSys](https://millionrounds.com/company/aquesys)** Series D · US **$44M** With 4 others
- **Jan** **[TopiVert](https://millionrounds.com/company/topivert)** Venture · GB **$6.8M** With 3 others
- **2013** 12 rounds
- **Dec** **[CSA Medical](https://millionrounds.com/company/csa-medical)** Series C · US **$16M** With 6 others
- **Dec** **[Sutro Biopharma](https://millionrounds.com/company/sutro-biopharma)** Series D · US · finsmes.com **$26M** With 5 others
- **Nov** **[Pulmocide](https://millionrounds.com/company/pulmocide)** Series A · GB · finsmes.com **$28M** With 4 others
- **Nov** **[Catabasis Pharmaceuticals](https://millionrounds.com/company/catabasis-pharmaceuticals)** Series B · US · finsmes.com **$32M** With 4 others
- **Nov** **[Delenex Therapeutics](https://millionrounds.com/company/delenex-therapeutics)** Series A · CH · startupticker.ch **$8.0M** With 4 others
- **Sept** **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Debt · US · canadianprivateequity.com **$12M** With 2 others
- **Sept** **[Arsanis](https://millionrounds.com/company/arsanis)** Series B · AT · biospace.com **$20M** With 3 others
- **Jul** **[OncoEthix](https://millionrounds.com/company/oncoethix)** Series B · CH · finsmes.com **$19M** With 3 others
- **Jun** **[WellNow Urgent Care Holdings](https://millionrounds.com/company/wellnow-urgent-care-holdings)** Seed · US **$4.1M** Sole investor
- **Mar** **[CardioKinetix](https://millionrounds.com/company/cardiokinetix)** Series E · US · finsmes.com **$23M** With 4 others
- **Feb** **[Catabasis Pharmaceuticals](https://millionrounds.com/company/catabasis-pharmaceuticals)** Venture · US · fiercebiotech.com **$9.0M** With 3 others
- **Jan** **[Ocular Therapeutix](https://millionrounds.com/company/ocular-therapeutix)** Series D · US · businesswire.com **$24M** With 3 others
- **2012** 11 rounds
- **Dec** **[Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics)** GB · finsmes.com **$6.0M** With 4 others
- **Oct** **[Health Essentials](https://millionrounds.com/company/health-essentials)** US · finsmes.com **Undisclosed** With 1 other
- **Oct** **[ReShape Medical](https://millionrounds.com/company/reshape-medical)** Series C · US · pevc.dowjones.com **$15M** With 2 others
- **Oct** **[Cibiem](https://millionrounds.com/company/cibiem)** Series A · US · finsmes.com **$10M** With 1 other
- **Sept** **[Karus Therapeutics](https://millionrounds.com/company/karus-therapeutics)** Series B · GB · pevc.dowjones.com **$7.6M** With 3 others
- **Jul** **[Cyterix Pharmaceuticals](https://millionrounds.com/company/cyterix-pharmaceuticals)** Venture · US **$7.3M** With 1 other
- **May** **[Sutro Biopharma](https://millionrounds.com/company/sutro-biopharma)** Series C · US · finance.yahoo.com **$17M** With 4 others
- **Apr** **[AlloCure](https://millionrounds.com/company/allocure)** Series B · US · masshightech.com **$25M** With 2 others
- **Apr** **[Good Start Genetics](https://millionrounds.com/company/good-start-genetics)** Series B · US · masshightech.com **$14M** With 2 others
- **Apr** **[Adimab](https://millionrounds.com/company/adimab)** Series F · US · adimab.com **$14M** With 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **12 named**

DD **David D. Milne** Member of the GP LLC i Filing they signed

ED **Eugene D. Hill, III** Member of the GP LLC i Filing they signed

EH **Eugene Hill** Executive Officer i Filing they signed

GM **Greg Madden** Executive Officer i Filing they signed

HA **Houman Ashrafian** Executive Officer i Filing they signed

JG **James Garvey** Member of the GP LLC i Filing they signed

KD **Kate D. Bingham** Member of the GP LLC i Filing they signed

LD **Lutz D. Giebel** Member of the GP LLC i Filing they signed

MB **Michael Balmuth** Executive Officer i Filing they signed

MD **Michael D. Ross** Member of the GP LLC i Filing they signed

PL **Paul LaViolette** Executive Officer i Filing they signed

TF **Thomas Flynn** Executive Officer i Filing they signed

We also hold **11** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **13 in all**

**[AqueSys](https://millionrounds.com/company/aquesys)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **$300M** Sept 2015

**[AcceleCare Wound Centers](https://millionrounds.com/company/accelecare-wound-centers)** Bought by Healogics **Undisclosed** Mar 2015

**[Convergence Pharmaceuticals](https://millionrounds.com/company/convergence-pharmaceuticals)** Bought by [Biogen Idec](https://millionrounds.com/fund/biogen-idec) **$675M** Jan 2015

**[OncoEthix](https://millionrounds.com/company/oncoethix)** Bought by Merck & Co. **Undisclosed** Dec 2014

**[Synarc](https://millionrounds.com/company/synarc)** Bought by BioClinica **Undisclosed** Mar 2014

**[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Bought by [Debiopharm Group](https://millionrounds.com/fund/debiopharm-innovat) **Undisclosed** Feb 2014

**[Rempex Pharmaceuticals](https://millionrounds.com/company/rempex-pharmaceuticals)** Bought by The Medicines Company **$464M** Dec 2013

**[Cadent](https://millionrounds.com/company/cadent)** Bought by [Align Technology](https://millionrounds.com/fund/align-technology) **Undisclosed** Mar 2011

**[Sadra Medical](https://millionrounds.com/company/sadra-medical)** Bought by [Boston Scientific](https://millionrounds.com/fund/boston-scientific) **$193M** Nov 2010

**[LensX Lasers](https://millionrounds.com/company/lensx-lasers)** Bought by [Alcon](https://millionrounds.com/fund/alcon) **Undisclosed** Jul 2010

**[Phase Forward](https://millionrounds.com/company/phase-forward)** Bought by [Oracle Corporation](https://millionrounds.com/fund/oracle) **$685M** Apr 2010

**[CHF Solutions](https://millionrounds.com/company/chf-solutions)** Bought by Gambro **Undisclosed** Jan 2010

**[Alantos Pharmaceuticals](https://millionrounds.com/company/alantos-pharmaceuticals)** Bought by [Amgen](https://millionrounds.com/fund/amgen) **Undisclosed** Jun 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

## Companies it bought

Acquisitions by the firm itself

**Ximedica** **Undisclosed** Nov 2014

New fund on file

**$421M**

raised in Mar 2022

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Series B Series A Series C

Median round joined **$30M** the round, not its cheque Alone, median **$12M**

Led 0 of 121 rounds **0%**

- **Sole investor:** 5 rounds
- **Last cheque:** Mar 2017
- **Exits:** 13 from the portfolio

Rounds by stage said on their site

- Series B *36*
- Series A *30*
- Series C *17*
- Venture *16*
- Series D *10*
- Series E *4*

Cheques by year Led Joined

2000 2017

Often in the room with

- [Accuitive Medical Ventures](https://millionrounds.com/fund/accuitive-medical-ventures) 13
- [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 13
- [Novo Holdings A/S](https://millionrounds.com/fund/novo-holdings-a-s) 12
- [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) 10
- [Polaris Partners](https://millionrounds.com/fund/polaris-partners) 10
- [The Carlyle Group](https://millionrounds.com/fund/the-carlyle-group) 10

**Pitching SV Life Sciences?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as SV Life Sciences. A count of rooms they were both in, not a relationship either has claimed.

[**Accuitive Medical Ventures** VC firm **13** rounds together](https://millionrounds.com/fund/accuitive-medical-ventures)[**Versant Ventures** VC firm **13** rounds together](https://millionrounds.com/fund/versant-ventures)[**Novo Holdings A/S** Growth equity **12** rounds together](https://millionrounds.com/fund/novo-holdings-a-s)[**New Leaf Venture Partners** VC firm **10** rounds together](https://millionrounds.com/fund/new-leaf-venture-partners)[**Polaris Partners** VC firm **10** rounds together](https://millionrounds.com/fund/polaris-partners)[**The Carlyle Group** Private equity **10** rounds together](https://millionrounds.com/fund/the-carlyle-group)[**HBM BioVentures** Growth equity **9** rounds together](https://millionrounds.com/fund/hbm-bioventures)[**OrbiMed** Private equity **8** rounds together](https://millionrounds.com/fund/orbimed)[**Clarus Ventures** VC firm **7** rounds together](https://millionrounds.com/fund/blackstone)[**Split Rock Partners** VC firm **7** rounds together](https://millionrounds.com/fund/split-rock-partners)[**Alta Partners** VC firm **6** rounds together](https://millionrounds.com/fund/alta-partners)[**Essex Woodlands Healthcare Partners** VC firm **6** rounds together](https://millionrounds.com/fund/essex-woodlands-health-ventures)

## Recently backed

The latest companies SV Life Sciences put money into.

[**Pulmocide** $30M · Mar 2017](https://millionrounds.com/company/pulmocide)[**Artios Pharma** $33M · Sept 2016](https://millionrounds.com/company/artios-pharma)[**Aligned TeleHealth** $12M · Aug 2016](https://millionrounds.com/company/aligned-telehealth)

## Quick answers about SV Life Sciences

### What does SV Life Sciences invest in?

SV Life Sciences invests most often at Series B and Series A (58% of the rounds on record).

### How active is SV Life Sciences?

121 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2017.

### What has SV Life Sciences invested in recently?

Its most recent investments on record: Pulmocide (Series B, Mar 2017), Artios Pharma (Series A, Sept 2016) and Aligned TeleHealth (Series A, Aug 2016).

### How big are SV Life Sciences's cheques?

The median round it joins is $30M.

### Does SV Life Sciences lead rounds?

Rarely, if at all: none of its 121 investments on record names it as the lead.

### Where does SV Life Sciences invest?

Most of the companies it backs are in the United States (69%), the United Kingdom (23%) and Switzerland (5%).

### Is SV Life Sciences investing now?

No investments in the last 12 months; the latest was in Mar 2017.

### Who does SV Life Sciences invest alongside?

Most often Accuitive Medical Ventures (13 rounds together), Versant Ventures (13 rounds together) and Novo Holdings A/S (12 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=sv-life-sciences) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=sv-life-sciences)